Japanese Encephalitis Vaccine (JEV)
Awarded Limited / Sole Source Justification Posted
- Solicitation number
- SPE2DP-25-D-0002
- Agency
- Medical Supply Chain Troop Support, Department of Defense
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- SPE2DP-25-D-0001 Federal IDV award
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Philadelphia, Pennsylvania 19111, United States
- Points of contact
-
- Jessica Delahoz jessica.delahoz@dla.mil (445) 737-3623
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency Troop Support Medical issued a sole source justification for Japanese Encephalitis Vaccine (JEV) with Emergent BioSolutions as the exclusive contractor. The justification authorizes contract SPE2DP-25-D-0002 based on Emergent BioSolutions being the only FDA-licensed manufacturer of JE-Vax in the United States, making them the sole responsible source capable of meeting the agency's requirements. The contract's total estimated value is $34,491,600, which includes a base period of $11,497,200 and two 12-month option periods at $11,497,200 each, with a performance period from January 29, 2025, through January 28, 2028. The vaccine is critical for protecting military personnel and DoD beneficiaries against Japanese Encephalitis virus when deployed to endemic areas in Asia and the Western Pacific. The sole source determination was made under federal acquisition regulations, specifically 10 U.S.C 4204(f) and 41 U.S.C. 3304(f), which allow for procurement from a single source when competition is not feasible.
Notice text
In accordance with FAR 6.305 Availability of the Justification, paragraph (a), the attached Justification and Approval for only one responsible source is hereby attached to this notice as required by 10 U.S.C 4204(f) and 41 U.S.C. 3304(f).
Awarded contract SPE2DP-25-D-0001 to unknown vendor for unknown amount on 2025-01-29.
Attachments
| File | Type | Posted |
|---|---|---|
| 24R0002_JEV_JA_Final_SIGNED_Redacted.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Japanese Encephalitis Vaccine (JEV) | Limited / Sole Source Justification | |
| Japanese Encephalitis Vaccine (JEV) | Pre-Solicitation | |
| Japanese Encephalitis Vaccine (JEV) | Pre-Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity